Cargando…
Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the developed world, with a global prevalence of around 25%. NAFLD is considered to be the hepatic manifestation of metabolic syndrome and is strongly associated with obesity, insulin resistance and dyslipi...
Autores principales: | Akhtar, Daud H., Iqbal, Umair, Vazquez-Montesino, Luis Miguel, Dennis, Brittany B., Ahmed, Aijaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943204/ https://www.ncbi.nlm.nih.gov/pubmed/31915606 http://dx.doi.org/10.14218/JCTH.2019.00028 |
Ejemplares similares
-
The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
por: Iqbal, Umair, et al.
Publicado: (2019) -
Atherogenic dyslipidemia
por: Manjunath, C. N., et al.
Publicado: (2013) -
Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease
por: Dibba, Pratima, et al.
Publicado: (2018) -
Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review
por: Tighe, Sean P., et al.
Publicado: (2020) -
Types of Physical Activity in Nonalcoholic Fatty Liver Disease and All-Cause and Cardiovascular Mortality
por: Kim, Donghee, et al.
Publicado: (2023)